Skip to main content

Table 1 Prevalence of genital chlamydia infection and socio-demographic factors and health care utilisation, sexual behaviour and self-reported STIs among men and women aged 18–25 years in Rogaland, Norway. N = 1535

From: Population based study of genital Chlamydia trachomatis prevalence and associated factors in Norway: A cross sectional study

  

Men (n = 605)

Women (n = 930)

n/N

%

95% CI

n/N

%

95% CI

Age

18-21

16/254

6.3

3.9-10.0

30/453

6.6

4.7-9.3

 

22-25

15/351

4.3

2.6-6.9

24/477

5.1

3.4-7.4

Marital status

Single

30/550

5.5

3.8-7.7

54/817

6.6

5.1-8.5

 

Married

1/55

1.8

0.3-9.6

0/113

0

0-3.2

Education, years

≤14

29/490

5.9

4.2-8.4

45/675

6.7

5.0-8.8

 

15+

2/115

1.7

0.5-6.1

9/255

3.5

1.9-6.6

Occupation

Employed

18/339

5.3

3.4-8.2

23/336

6.8

4.6-10.1

 

Unemployed

4/27

14.8

5.9-32.5

4/37

10.8

4.3-24.7

 

Student/pupil

8/197

4.1

2.7-7.8

20/479

4.2

2.7-6.4

 

Other/Unknown

1/42

2.4

0.4-12.3

7/78

9.0

4.4-17.4

Country of birth

Norway

28/575

4.9

3.4-7.0

52/876

5.9

4.6-7.7

 

Europe/North America

0/13

0

0-22.8

0/29

0

0.11.7

 

Other countries

3/17

17.6

0.4-12.3

2/29

8.8

3.0-23.0

Presence of a youth clinic in municipality

Yes

20/307

6.5

4.3-9.9

38/589

6.5

4.7-8.7

No

5/15

33.3

15.2-58.3

1/50

2.0

0.4-10.5

 

Do not know

6/283

2.1

1.0-4.6

15/291

5.2

3.2-8.3

Using youth clinic services

Yes

2/66

3.0

0.8-10.4

23/312

7.4

5.0-10.8

No

29/539

5.4

3.8-7.6

31/618

5.0

3.6-7.0

Consulted a family doctor on STI

Yes

14/191

7.3

4.4-11.9

33/514

6.4

4.6-8.9

 

No

17/414

4.1

2.6-6.5

21/416

5.0

3.3-7,6

Number of partners during last year

0

1/24

4.2

0.7-20.2

0/14

0

0-21.5

1

2/303

0.7

0.2-2.4

15/563

2.7

1.6-4.4

 

2-3

11/154

7.1

4.0-12.3

19/222

8.6

5.6-13.0

 

4-5

9/66

13.6

7.3-23.9

12/83

14.5

8.5-23.6

 

5+

8/58

13.8

7.2-24.9

8/48

16.7

8.7-29.6

Total number of partners

1

0/114

0

0-3.3

0/184

0

0-2.1

 

2-3

3/130

2.3

0.8-6.6

5/212

2.4

1.0-5.4

 

4-5

1/103

1.0

0.2-5.3

5/157

3.2

1.4-7.2

 

6-10

11/124

8.9

5.0-15.2

23/215

10.7

7.2-15.5

 

10+

16/134

11.9

7.5-18.5

21/162

13.0

8.6-19.0

Previoulsy tested for chlamydia

Yes

11/161

6.8

3.9-11.8

35/510

6.9

5.0-9.4

 

No

20/444

4.5

2.9-6.9

19/420

4.5

2.9-7.0

Previously diagnosed with chlamydia

Yes

4/57

7.0

2.8-16.7

19/152

12.5

8.2-18.7

 

No

27/548

4.9

3.4-7.1

35/778

4.5

3.5-6.2

Previoulsy diagnosed with genital warts

Yes

3/40

7.5

2.6-19.9

1/64

1.6

0.3-8.3

No

28/565

5.0

3.5-7.1

53/866

6.1

4.7-7.9

Previously diagnosed with genital herpes

Yes

2/2

100

0.34-100

0/16

0

0-19.4

 

No

29/603

4.8

3.4-6.8

54/914

5.9

4.6-7.6

Presence of symptoms

Yes

10/83

12.0

6.7-20.8

20/329

6.1

4.0-9.2

 

No

21/522

4.0

2.7-6.1

34/601

5.7

4.1-7.8

Sex with a person of the same sex

Yes

0/28

0

0-12.1

5/65

7.7

3.3-16.8

 

No

31/577

5.4

3.8-7.5

49/865

5.7

4.3-7.4

Method with casual partner

No contraception

12/136

8.8

5.1-14.8

10/99

10.1

5.6-17.6

 

Condom

7/135

5.2

2.5-10.3

9/134

6.7

3.6-12.2

 

Hormonal

8/135

5.9

3.0-11.3

29/345

8.4

5.9-11.8

 

Other

4/199

2.0

0.8-5.0

6/352

1.7

0.8-3.7

Method with long-term partner

No contraception

8/114

7.0

3.6-13.2

11/129

8.5

4.8-14.6

 

Condom

4/86

4.7

1.8-11.4

1/83

1.2

0.2-6.5

 

Hormonal

15/331

4.5

2.8-7.3

34/588

5.8

4.2-8.0

 

Other

4/74

5.4

2.1-13.1

8/130

6.2

3.2-11.7

Constant partner

Yes

8/297

2.7

1.4-5.2

22/520

4.2

2.8-6.3

 

No

23/308

7.5

5.0-11.0

32/410

7.8

5.6-10.8